Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

5 Dec 2019 07:00

RNS Number : 7186V
MJ Gleeson PLC
05 December 2019
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, will today hold its Annual General Meeting in Sheffield. Dermot Gleeson, Chairman, will make the following comments:

"Demand at Gleeson Homes is strong with net reservations since the start of the current financial year to 30 June 2020 ("FY2020") up more than 10% compared with the same period last year.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

"The division currently has 64 active sites, compared with 62 at this time last year, but expects to open significantly more sites in the second half of FY2020.

"Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive.

 

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2019 of approximately 10% compared with the prior half year total of 691 units; and an increase in completions for FY2020 of at least 10% compared with the prior year total of 1,529 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. The majority of the division's land sales are expected in the second half of FY2020. Accordingly, and in line with our expectations, results for the first half are expected to be lower than the unusually high results for the first half last year.

"The division's land pipeline currently consists of 64 sites which have the potential to deliver approximately 22,175 plots. The portfolio includes 10 sites which now have planning permission.

"Against this background the Board remains confident that the Group's results for FY2020 will be in line with expectations.

"We announced in September the appointment of Andrew Coppel and Fiona Goldsmith to the Board as non-executive Directors with effect from 1st October 2019. Colin Dearlove, Senior Independent Director and Ross Ancell, Non-Executive Director will be stepping down from the Board in June 2020. The Board would like to thank both Colin and Ross for the invaluable guidance and support they have provided over the years."

 

5 December 2019

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKMMGZVDGGLZM
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.